Switching CF patients from previous pancreatic enzyme replacement therapy to ZENPEP™ (pancrelipase delayed-release capsules) improves symptom control of exocrine pancreatic insufficiency (EPI)

Autor: Heubi, J.E., Straforini, C., Thieroff-Ekerdt, R.

Publikováno v: In Journal of Cystic Fibrosis 2010 9 Supplement 1:S77-S77

EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.

Autor: Wooldridge JL; Cincinnati Children's Hospital Medical Center, Division of Pulmonary Medicine, ML 2021, 3333 Burnet Ave., Cincinnati, OH 45229, USA. jamie.wooldridge@cchmc.org, Heubi JE, Amaro-Galvez R, Boas SR, Blake KV, Nasr SZ, Chatfield B, McColley SA, Woo MS, Hardy KA, Kravitz RM, Straforini C, Anelli M, Lee C

Publikováno v: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2009 Dec; Vol. 8 (6), pp. 405-17. Date of Electronic Publication: 2009 Aug 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Metabolic markers of protein maldigestion after a ¹⁵N test meal in minipigs with pancreatic exocrine insufficiency.

Autor: Mary, Florence, Moesseler, Anne, Khodorova, Nadezda, Foucault-Simonin, Angélique, Benamouzig, Robert, Tomé, Daniel, Gregory, Peter Colin, Gaudichon, Claire

Publikováno v: American Journal of Physiology: Gastrointestinal & Liver Physiology; Feb2018, Vol. 314 Issue 2, pG223-G230, 8p